Research use only · Lyophilised material · Not a medicine · Not for human or veterinary use · Disclaimer

Comparison · not a ranking

PT-141 compared with Retatrutide

PT-141 and Retatrutide are separate catalogue items. They are not interchangeable.A CoA for every lot; each vial carries a printed lot number that matches it. Request yours and we email it within 2 hours. Research use only. Not a medicine.

Last verified 9 Nov 2026. UK prices checked daily.

PT-141 and Retatrutide are two distinct catalogue compounds. PT-141 is a 7-residue cyclic peptide, while Retatrutide is a 39-residue peptide (lipidated). PT-141: C50H68N14O10, 1025.2 g/mol, CAS 189691-06-3. Retatrutide has no sourced formula or molecular weight on its reference record yet. By sequence, PT-141 is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH. In short, their sequences differ in length (7 versus 39 residues). Each has its own reference record, which lists the source for every figure above. Sable Peptides, a UK supplier operating since 2019, lists both as lyophilised research material; every vial carries a lot number and a certificate of analysis exists for every lot — request yours at /coa-request and we email it within 2 hours. This intro compares identity only and ranks neither compound. Research use only. Not a medicine. Not for human or veterinary use.

Sources: pubchem.ncbi.nlm.nih.gov · pubchem.ncbi.nlm.nih.gov

/ref/pt-141 · /ref/retatrutide

PT-141 and Retatrutide are two records in the Sable Peptides catalogue at https://www.sablepeptides.co.uk/versus/pt-141/retatrutide. These prices are both Sable catalogue prices. They are not a comparison with another shop. This page does not rank either compound. Each page shows the catalogue price. A market comparison appears only when an exact, current, approved listing for that size is on record. Only a row with the same amount is a like-for-like price.

Research use only. Not a medicine. Not for human or veterinary use. Disclaimer

Same amount, both catalogue prices. Not a comparison with another seller.
AmountPT-141Retatrutide
5 mg£14.29£23.99
10 mg£12.00£23.50

Reference facts

FactPT-141Retatrutide
Molecular weight1025.2 g/mol–
Molecular formulaC50H68N14O10–
CAS number189691-06-3–
Compound classcyclic peptidepeptide (lipidated)

Sources: pubchem.ncbi.nlm.nih.gov, pubchem.ncbi.nlm.nih.gov Verified 2026-11-09

Category
PT-141Short sequences
RetatrutideAnalogues
Research use only
PT-141Yes
RetatrutideYes
Vials
PT-1412
Retatrutide8
Record
PT-141pt-141
Retatrutideretatrutide

PT-141 · Retatrutide

Questions this page answers

How does PT-141 compare with Retatrutide?
Same vial amounts are shown side by side with each catalogue price. Different amounts are not treated as the same price. No effect is compared, and another seller is not compared.
Which is better?
This page does not say. It does not rank safety, strength, or effect.
What is the lowest catalogue price per mg for PT-141 and Retatrutide?
PT-141: £1.20/mg on the 10 mg vial (£12.00). Retatrutide: £1.48/mg on the 40 mg vial (£59.00). Different compounds; this is a catalogue price fact, not a ranking.
How many vial sizes are listed for each?
PT-141: 5 mg, 10 mg. Retatrutide: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg.

Both compounds

Related research

PT-141 and Retatrutide are different research compounds, compared here by vial sizes, price per mg and published identifiers. Sable Peptides sells PT-141 from £12.00 and Retatrutide from £23.50. Every lot has an HPLC and mass-spectrometry Certificate of Analysis, emailed within 2 hours of a request.

Updated